Corporate Liaison and Ventures
Monday, September 9, 2024

Get an early look at the transformative biomedical research happening at Gladstone. Join the Industry Partnership Forum to talk to Gladstone scientists, learn more about scientific programs that are ready for translational opportunities, and discover how you can partner with our labs.

Presenting scientists will be available for a limited number of one-on-one meetings with both in-person and remote attendees. 

Program and Speakers

Time Speaker
10:00am Welcome
Ariel Brumbaugh, PhD, Director, Biosciences Business Development, Gladstone Institutes
10:05am Introduction to Gladstone
Deepak Srivastava, MD, President, Gladstone Institutes
10:10am Avatrial: An Integrated Network Solution to Cancer 
Kourosh Saeb-Parsy, CEO and Founder of Avatrial 
Milner Therapeutics Institute, University of Cambridge
10:35am Retronix: Retron Mediated Exon-Sized Genome Insertion Using an All-RNA System
Seth Shipman, PhD, Associate Investigator, Gladstone Institutes
11:00am Break
11:20am Vitra Labs: Transforming the IVF Paradigm
Ivana Muncie-Vasic, PhD, CEO and Founder of Vitra Labs 
11:45am CoSyne: Precision Medicine through Polymathic AI 
Louwai Muhammed, CEO and Co-Founder of CoSyne Therapeutics
Milner Therapeutics Institute, University of Cambridge
12:10pm Lunch
12:55pm Recent Progress in iPS Cell Research and Application
Shinya Yamanaka, MD, PhD, Senior Investigator, Gladstone Institutes
Director Emeritus and Professor, Center for iPS Cell Research and Application (CiRA), Kyoto University, Japan
1:20pm Title TBD
Katerina Akassoglou, PhD, Senior Investigator, Gladstone Institutes
Director, Gladstone-UCSF Center for Neurovascular Brain Immunology
1:45pm clock.bio—Extending and Improving the Quality of Life by Reversing the Harmful Effects of Time in Our Cells
Markus Gstöttner, CEO of clock.bio 
Milner Therapeutics Institute, University of Cambridge
2:10pm Break
2:30pm Title TBD
Yadong Huang, MD, PhD, Senior Investigator, Gladstone Institutes
Director, Center for Translational Advancement, Gladstone Institutes
2:55pm Tapping the Untapped: Harnessing Venture Opportunities from the University of Cambridge and Beyond
Sir Tony Kouzarides, CEO and Co-Founder of Vellos
Milner Therapeutics Institute, University of Cambridge
3:20pm Closing Remarks
Stephen Freedman, PhD, Vice President, Corporate Liaison and Ventures, Gladstone Institutes
3:30pm Networking Reception

 

Register to attend in person or virtually. 

Details

Dates
September 9, 2024
Time
10:00am-5:00pm PDT
Location
Mahley Auditorium & Online
1650 Owens Street, San Francisco, CA 94158
Audience
Public, Scientific
Contact(s)






Getting There

1650 Owens Street, San Francisco, CA 94158

Diversity, Equity, and Inclusion

At Gladstone, we are committed to providing events and professional development activities that resonate with our community’s diverse members. Our goal is to develop creative programming that encompasses a wide variety of ideas and perspectives to inspire, educate, and engage with everyone within our walls.

We want to effect positive change through our events and activities by providing a platform for discussions on important topics related to increasing diversity and inclusiveness in the sciences.